Cuprina Holdings (Cayman) (CUPR) Revenue & Revenue Breakdown
Cuprina Holdings (Cayman) Revenue Highlights
Latest Revenue (Y)
$100.77K
Latest Revenue (Q)
$26.79K
Cuprina Holdings (Cayman) Revenue by Period
Cuprina Holdings (Cayman) Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $100.77K | 78.05% |
| 2022-12-31 | $56.60K | -3.26% |
| 2021-12-31 | $58.50K | - |
Cuprina Holdings (Cayman) generated $100.77K in revenue during NA 2023, up 78.05% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Cuprina Holdings (Cayman) Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $26.79K | - |
Cuprina Holdings (Cayman) generated $26.79K in revenue during Q4 2025, up 0.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Cuprina Holdings (Cayman) Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CRIS | Curis | $9.44M | - |
| CUPR | Cuprina (Cayman) Limited Class A Ordinary Shares | $100.77K | $26.79K |
| ASBP | Aspire Biopharma | $6.20K | $63.10K |
| PULM | Pulmatrix | - | - |
| CURX | Curanex Pharmaceuticals | - | - |
| BCTX | BriaCell Therapeutics | - | - |
| SYBX | Synlogic | - | - |
| PALI | Palisade Bio | - | $500.00K |
| PCSA | Processa Pharmaceuticals | - | - |